1110038F14Rik Activators
UPF0488 protein C8orf33 homolog Activators encompass a range of chemical compounds that serve to enhance the protein's functional activity through modulation of various signaling pathways. Forskolin, by raising intracellular cAMP levels, indirectly augments the activity of UPF0488 protein C8orf33 homolog via PKA-mediated phosphorylation events, which likely influence the proteins and pathways UPF0488 protein C8orf33 homolog is involved with. Ionomycin and A23187, both acting as calcium ionophores, increase intracellular calcium concentrations, engaging calcium-dependent signaling that UPF0488 protein C8orf33 homolog is a part of, thus potentiating its activity. Furthermore, PMA stimulates PKC, which can lead to the phosphorylation of substrates involved in pathways where UPF0488 protein C8orf33 homolog functions, and Isoproterenol activates beta-adrenergic receptors, culminating in enhanced cAMP levels and PKA activation, potentially affecting UPF0488 protein C8orf33 homolog's activity through phosphorylation.
In addition to these, LY294002's inhibition of PI3K and U0126's inhibition of MEK1/2 can lead to alterations in the signaling landscape, which may indirectly result in the enhanced activity of UPF0488 protein C8orf33 homolog. Epigallocatechin gallate, by inhibiting certain protein kinases, and Sphingosine-1-phosphate, through its receptor-mediated signaling, modulate the cellular signaling milieu in ways that could amplify the activity of UPF0488 protein C8orf33 homolog. IBMX's role in preventing phosphodiesterase activity and the subsequent rise in cAMP levels also supports PKA activation, which influences the signaling pathways involving UPF0488 protein C8orf33 homolog. Lastly, Bisindolylmaleimide I, as a PKC inhibitor, might indirectly upregulate UPF0488 protein C8orf33 homolog's function by shifting the balance of signaling pathways, and Thapsigargin, by disrupting calcium homeostasis, may activate signaling pathways crucial for UPF0488 protein C8orf33 homolog's role in the cell. Collectively, these activators work through distinct yet interconnected pathways to enhance the functional activity of UPF0488 protein C8orf33 homolog without affecting its expression levels directly.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, leading to the activation of calcium-dependent signaling pathways. Since UPF0488 protein C8orf33 homolog plays a role in calcium-dependent processes, ionomycin enhances its activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which is involved in a variety of signaling pathways. PKC activation can enhance the activity of UPF0488 protein C8orf33 homolog by promoting phosphorylation events within its signaling network. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore that raises intracellular calcium, stimulating calcium-dependent proteins and pathways. This can indirectly enhance the activity of UPF0488 protein C8orf33 homolog, which is implicated in calcium-mediated signaling. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a synthetic catecholamine that activates beta-adrenergic receptors, leading to increased cAMP and subsequent activation of PKA. PKA signaling can enhance the activity of UPF0488 protein C8orf33 homolog through phosphorylation of associated proteins. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. By inhibiting PI3K, it can lead to the modulation of downstream pathways such as AKT signaling, which might indirectly increase the activity of UPF0488 protein C8orf33 homolog if it is involved in AKT-related signaling pathways. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that has been shown to inhibit certain protein kinases. This inhibition may lead to a shift in the balance of signaling pathways, potentially enhancing the activity of UPF0488 protein C8orf33 homolog through indirect effects on its signaling environment. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P is a bioactive lipid that activates sphingosine-1-phosphate receptors and can modulate signaling pathways, including those involving calcium mobilization. Such modulation can enhance the activity of UPF0488 protein C8orf33 homolog by influencing its signaling milieu. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, leading to increased cAMP levels which can activate PKA. Through PKA activation, IBMX may enhance the activity of UPF0488 protein C8orf33 homolog by affecting the phosphorylation status of proteins in related pathways. | ||||||